Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end? | 0 | 546 | March 1, 2015 | |
| A potential new approach for the treatment of schizophrenia | 2 | 478 | December 9, 2021 | |
| Drug development in schizophrenia: are glutamatergic targets still worth aiming at? | 0 | 603 | April 15, 2015 | |
| Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators | 4 | 327 | August 18, 2018 | |
| From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment | 3 | 801 | November 23, 2016 |